[图书][B] T lymphocytes and their receptors in immunologic recognition

BD Brondz, BD Brondz - 1988 - books.google.com
Chapter 1. The Major Histocompatibility Complex (MHC), and the Involvement of its Products
in Antigen Recognition 1.1. Properties and Biologic Roles of the MHC Products 1.1. 1. MHC …

An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions

PK Lala, IFC McKenzie - Immunology, 1982 - ncbi.nlm.nih.gov
Small lymphocyte subsets were characterized radioautographically on the basis of several
surface markers, viz. surface Ig (S-Ig), Thy-1 and Lyt (Ly-1, Ly-2 and 3) antigens in host …

Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours.

JJ Mulé, I Hellström, KE Hellström - The American Journal of …, 1982 - ncbi.nlm.nih.gov
Using a cell separation technique to isolate mononuclear leukocytes from solid tumors in
conjunction with combined radioautography and two-color immunofluorescence, we have …

Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases

K Yoshida, T Tachibana - Journal of the National Cancer …, 1985 - academic.oup.com
The growth of syngeneic ascites MM48 tumor cells implanted in a hind footpad of a C3H/He
mouse slowed at 10–12 days after tumor implantation. At that time, no killer activity was …

Phenotype of Syngeneic Tumor-specific Cytotoxic T-Lymphocytes and Requirements for Their in Vitro Generation from Tumor-bearing Host and Immune Spleens

HD Bear, BM Susskind, KA Close, SK Barrett - Cancer research, 1988 - AACR
Cells required for the in vitro generation of syngeneic cytotoxic T-lymphocytes (CTL) against
the P815 mastocytoma in the DBA/2 mouse strain were investigated. For both immune and …

Tumor bearer T cells suppress BCG-potentiated antitumor responses: I. Requirements for their effect

E Hawrylko - Cellular Immunology, 1982 - Elsevier
Mice bearing established syngeneic tumors fail to reject them when immunized according to
protocols based on optimal conditions for BCG potentiation of specific delayed-type …

In Vivo and in Vitro Antitumor Activity Expressed by Cells of Concomitantly Immune Mice

RL Tuttle, VC Knick, CR Stopford, G Wolberg - Cancer research, 1983 - AACR
Growth of a primary tumor is often accompanied by the development of resistance to
subsequent challenge implants of the same tumor, ie, concomitant immunity. Using the P815 …

Changes in the host lymphocyte subsets during chemical carcinogenesis

P Brodt, PK Lala - Cancer research, 1983 - AACR
Abstract Changes in small lymphocyte subsets in the lymphoid organs of young C3H mice
were studied following im injection of a carcinogenic dose of 3-methylcholanthrene in …

Preliminary characterization of a soluble immunosuppressive molecule from DBA/2 spleen cells using monoclonal antibody immunoadsorbence

JK Steele, AT Stammers, A Chan, T Maier, JG Levy - Cellular immunology, 1985 - Elsevier
In a previous publication a monoclonal antibody (B16G) which appeared to recognize T
suppressor cells and a T-suppressor factor (TsF) in the spleens of DBA/2 mice was …

Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor

T Maier, JG Levy - Cancer Immunology, Immunotherapy, 1982 - Springer
DBA/2 mice inoculated with either cells from the syngeneic P815 tumor or tumor cell
membrane extracts develop T suppressor cells which suppress the in vitro generation of …